Spruce Biosciences (SPRB)
46.00
+3.27 (7.65%)
Upcoming Events
Latest Headlines
Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
October 15, 2026 4:05 PM - BizWire
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
October 8, 2026 4:05 PM - BizWire
B.Riley Reiterates Buy Rating on Spruce Biosciences, Inc. (SPRB)
October 5, 2026 5:07 AM - StreetInsider
Spruce Biosciences (SPRB) Reiterated at Market Outperform by Citizens on TA-ERT Therapy Lead
September 24, 2026 4:19 AM - StreetInsider
Spruce Biosciences (SPRB) Reiterated at Market Outperform by Citizens
September 18, 2026 5:20 AM - StreetInsider
Lake Street Starts Spruce Biosciences, Inc. (SPRB) at Buy
September 17, 2026 7:46 AM - StreetInsider
Spruce Biosciences Announces Launch of MPS3BStudy.com
August 26, 2026 8:00 AM - BizWire
H.C. Wainwright Reiterates Buy Rating on Spruce Biosciences, Inc. (SPRB)
August 26, 2026 6:43 AM - StreetInsider
Spruce Biosciences BLA filing for rare disease drug on track for 2026
August 24, 2026 8:03 AM - StreetInsider
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
August 24, 2026 8:00 AM - BizWire
Spruce Biosciences, Inc. (SPRB) PT Lowered to $104 at Guggenheim
August 17, 2026 6:56 AM - StreetInsider
Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: ORBIMED ADVISORS LLC
August 14, 2026 5:49 PM - SEC Filing
Form SCHEDULE 13G/A SPRUCE BIOSCIENCES, INC. Filed by: ADAR1 Capital Management, LLC
August 14, 2026 4:58 PM - SEC Filing
Form SCHEDULE 13G/A SPRUCE BIOSCIENCES, INC. Filed by: CITADEL ADVISORS LLC
August 14, 2026 4:19 PM - SEC Filing
Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: AWM Investment Company, Inc.
August 14, 2026 2:05 PM - SEC Filing
Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss
August 13, 2026 4:10 AM - StreetInsider
Form 10-Q SPRUCE BIOSCIENCES, INC. For: Jun 30
August 12, 2026 9:11 AM - SEC Filing
Form 8-K SPRUCE BIOSCIENCES, INC. For: Aug 12
August 12, 2026 9:05 AM - SEC Filing
Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 12, 2026 9:00 AM - BizWire
Two foundations invest $5.5M in Spruce Biosciences for rare disease access
August 12, 2026 8:01 AM - StreetInsider
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
August 12, 2026 8:00 AM - BizWire
Form SCHEDULE 13G/A SPRUCE BIOSCIENCES, INC. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
August 4, 2026 7:51 PM - SEC Filing
Spruce Biosciences names new VP of clinical development
August 3, 2026 8:00 AM - StreetInsider
Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development
August 3, 2026 8:00 AM - BizWire
Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: BlackRock, Inc.
July 30, 2026 11:19 AM - SEC Filing
Form 4 SPRUCE BIOSCIENCES, INC. For: Jul 27 Filed by: Quartel Adrian W
July 29, 2026 4:11 PM - SEC Filing
Form 3 SPRUCE BIOSCIENCES, INC. For: Jul 27 Filed by: Quartel Adrian W
July 29, 2026 4:10 PM - SEC Filing
Form SCHEDULE 13G SPRUCE BIOSCIENCES, INC. Filed by: HIRSCHMAN ORIN
July 27, 2026 4:05 PM - SEC Filing
Form 8-K SPRUCE BIOSCIENCES, INC. For: Jul 27
July 27, 2026 8:05 AM - SEC Filing
Spruce Biosciences names Adrian Quartel as chief medical officer
July 27, 2026 8:00 AM - StreetInsider
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
July 27, 2026 8:00 AM - BizWire
Full Article List
